Supplemental material
Open access
1,463
Views
35
CrossRef citations to date
0
Altmetric
Original Articles
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
Yingzhu ChenSchool of Laboratory Medicine and Life Science, Institute of Medical VirologyWenzhou Medical University, Wenzhou325035, China;Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Shuai LuKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Hao JiaSchool of Laboratory Medicine and Life Science, Institute of Medical VirologyWenzhou Medical University, Wenzhou325035, China;Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Yao DengKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Jianfang ZhouKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Baoying HuangKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Yueyang YuKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Jiaming LanKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Wenling WangKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, China
, Yongliang LouSchool of Laboratory Medicine and Life Science, Institute of Medical VirologyWenzhou Medical University, Wenzhou325035, China
, Kun QinKey Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, ChinaCorrespondence[email protected]
& Wenjie TanSchool of Laboratory Medicine and Life Science, Institute of Medical VirologyWenzhou Medical University, Wenzhou325035, China;Key Laboratory of Medical Virology, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing102206, ChinaCorrespondence[email protected]
show all
Pages 1-7
|
Received 30 Sep 2016, Accepted 13 Feb 2017, Published online: 15 Jan 2019
Related Research Data
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
Source:
Informa UK Limited
Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
Source:
MDPI AG
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
Source:
Informa UK Limited
Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.